Oncogenesis Contents: 30 May 2022

The latest content from Oncogenesis: 30 May 2022

The interferon-β/STAT1 axis drives the collective invasion of skin squamous cell carcinoma with sealed intercellular spaces Yuji Kumagai, Junko Nio-Kobayashi [...] Hisashi Haga Article | 24 May 2022 | Article number: 27 |  doi: 10.1038/s41389-022-00403-9

GSK3β palmitoylation mediated by ZDHHC4 promotes tumorigenicity of glioblastoma stem cells in temozolomide-resistant glioblastoma through the EZH2–STAT3 axis Chenggang Zhao, Huihan Yu [...] Xueran Chen Article | 23 May 2022 | Article number: 28 |  doi: 10.1038/s41389-022-00402-w

Tumor suppressor p53 restrains cancer cell dissemination by modulating mitochondrial dynamics Trinh T. T. Phan, Yu-Chun Lin [...] Lih-Yuan Lin Article | 19 May 2022 | Article number: 26 |  doi: 10.1038/s41389-022-00401-x

Estradiol-mediated inhibition of DNMT1 decreases p53 expression to induce M2-macrophage polarization in lung cancer progression Yung-Ching Chen, Ming-Jer Young [...] Jan-Jong Hung Article | 19 May 2022 | Article number: 25 |  doi: 10.1038/s41389-022-00397-4

Analysis of the metabolic proteome of lung adenocarcinomas by reverse-phase protein arrays (RPPA) emphasizes mitochondria as targets for therapy Laura Torresano, Fulvio Santacatterina [...] José M. Cuezva Article | 09 May 2022 | Article number: 24 |  doi: 10.1038/s41389-022-00400-y

Neutrophils and polymorphonuclear myeloid-derived suppressor cells: an emerging battleground in cancer therapy Hans Raskov, Adile Orhan [...] Ismail Gögenur Review Article | 03 May 2022 | Article number: 22 |  doi: 10.1038/s41389-022-00398-3

Cytoglobin attenuates pancreatic cancer growth via scavenging reactive oxygen species Dinh Viet Hoang, Le Thi Thanh Thuy [...] Norifumi Kawada Article | 03 May 2022 | Article number: 23 |  doi: 10.1038/s41389-022-00389-4

Neuron-specific enolase promotes stem cell-like characteristics of small-cell lung cancer by downregulating NBL1 and activating the BMP2/Smad/ID1 pathway Lin Lu, Zhiqiang Zha [...] Guolong Liu Article | 29 April 2022 | Article number: 21 |  doi: 10.1038/s41389-022-00396-5

Journal Info Submit Manuscript RSS Feed

This email has been sent to ignoble.experiment@arconati.us by Oncogenesis.

Unsubscribe Manage Alerts Privacy policy Contact us

Springer Nature Limited is a company registered in England and Wales under Company Number 785998 with its registered office at The Campus, 4 Crinan Street, London, N1 9XW, United Kingdom

Nature is part of Springer Nature. © 2022 Springer Nature Limited. All rights reserved.